Target of rapamycin inhibitors (TOR‐I) vs calcineurin inhibitors (CNI): main outcomes
Outcomes (up to 2 years for primary outcomes) · primary immunosuppression in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
- Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant… 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found